Tirzepatide offers may be discounted for the first supply, quoted as an annual equivalent or presented as a month-to-month bundle. The smallest printed figure can th
Tirzepatide offers may be discounted for the first supply, quoted as an annual equivalent or presented as a month-to-month bundle. The smallest printed figure can therefore require the largest initial payment. These five named routes make those conditions part of the comparison.
Injection Index compares compounded tirzepatide offers separately from branded Zepbound. The ingredient name does not make the products equivalent or establish FDA approval of a compound. The purpose is to understand the selected offer, not to identify a clinically superior medicine or a universally cheapest provider.
Advertised compounded tirzepatide
A stated monthly compounded-medicine price, with important prescription and refund checkpoints.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Compounded tirzepatide promotional floor; term and renewal conditions
SnagRx advertises low flat monthly prices, but longer subscription terms and its medically limited refund rule qualify the cancellation headline.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
GLP-1 plus GIP offer; confirm actual compounded preparation and terms
AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Compounded tirzepatide then $280 per four-week supply
Enhance.MD publishes distinct introductory and continuing rates, including $49 then $212 for its semaglutide plan; combined-drug marketing is not approval or superiority evidence.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Tirzepatide monthly; $125/mo equivalent annual commitment billed $1,500 upfront
Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Keep the actual preparation, quantity and supply period visible. Compare the initial charge and ordinary renewal, then ask what payment term qualifies for a promotion. An annual plan should show the full advance bill, and a four-week refill should not be called a calendar month. Clinical access, supplies and shipping belong in the complete quotation. Read the related care guide for a wider treatment discussion.
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. Use the tirzepatide product’s rate rather than the lower semaglutide price. The no-membership structure can simplify one line of the bill, while dispensed amount and the reason for compounding remain separate questions.
CoreAge’s current product pages list compounded semaglutide at $99 per month and compounded tirzepatide at $149, with no membership fee and free delivery if prescribed. Confirm the actual amount, billing interval and dispensing pharmacy. Its refund policy has pharmacy-approval and elapsed-time limits; cancellation should not be assumed to refund a prepared prescription.
Read the full CoreAge Rx review to compare the care pathway, prescription and recurring order.
SnagRx describes a clinician-reviewed compounded supply with a patient portal for refills. Its marketing separates no-membership pricing from selected subscription discounts. The product and pharmacy remain individualized prescription facts, while its prominent promotional price needs a term and renewal check. The tirzepatide promotion has its own amount and term conditions. Confirm the selected supply and later invoice, and do not assume a cancellation headline means an already prepared or purchased order can be refunded.
SnagRx currently promotes compounded semaglutide at $69 and tirzepatide at $119 per month, with medication, supplies, doctor review and free shipping described as included. It distinguishes month-to-month cancellation from subscribe-and-save term discounts. Sales are generally final, with unused-term refunds tied to medical ineligibility. Confirm promotion eligibility, selected term, quantity and renewal before treating the floor as guaranteed indefinitely.
Read the full SnagRx review to compare the care pathway, prescription and recurring order.
AltRx’s self-pay pathway includes a medical review and pharmacy fulfillment when appropriate. The page names independently operated pharmacy partners and distinguishes its compounded offers from branded product listings. A low promotional rate does not establish equivalent outcomes or FDA approval of the compounded preparation. The higher GLP-1 plus GIP card should be used for this comparison, with the actual ingredient and preparation confirmed. A lower GLP-1 headline belongs to a different offer and should not be carried into a tirzepatide list.
AltRx currently displays a GLP-1 offer from $89 per month and GLP-1 plus GIP from $149, with separate branded product prices. Its membership includes consultation, prescription fulfillment when appropriate, shipping and clinician support; no separate membership fee is advertised. Confirm the actual compound, dispensed quantity and recurring terms. Self-reported member outcomes are not independent clinical evidence.
Read the full AltRx review to compare the care pathway, prescription and recurring order.
Enhance.MD connects clinician-directed compounded programs with a four-week supply, support and stated laboratory inclusion. Its semaglutide and tirzepatide offers have separate introductory and later prices. The different program names and supply periods should remain visible when the ongoing care budget is compared. The page explicitly separates the first tirzepatide payment from the later four-week price. Retaining both prevents an apparently cheap introduction from becoming an understated ongoing treatment budget.
Enhance.MD currently lists compounded semaglutide at $49 for the first month and $212 afterward; tirzepatide is $99 initially and $280 afterward. Its cards describe four weeks of medication, provider support and metabolic labs every six months. Confirm shipment, subscription and supply terms: four weeks is not a calendar month, and a low initial charge is not the ongoing budget.
Read the full Enhance.MD review to compare the care pathway, prescription and recurring order.
Trimi describes individualized compounded semaglutide and tirzepatide prescriptions with provider review, supplies and shipment. It offers materially different annual and monthly payment commitments. The named pharmacy pathway helps identify what to ask, while regulatory status and clinical rationale still need separate consideration. The annual tirzepatide equivalent is tied to a twelve-month commitment and $1,500 advance bill. It should be compared with the separately quoted month-to-month plan, not presented as a $125 monthly checkout.
Trimi’s current compounded semaglutide choices are $175 month-to-month or a $99 monthly equivalent on a twelve-month commitment billed $1,188 upfront. Tirzepatide is $235 monthly or $125 equivalent with $1,500 upfront. It lists provider review, supplies and shipping with no membership fee. Confirm selected term, actual amount supplied and refund rules; the annual equivalent is not a monthly payment.
Read the full Trimi review to compare the care pathway, prescription and recurring order.
Ask for the exact tirzepatide preparation and full supply-period quotation. A price-first comparison should still retain the prescription rationale and cancellation terms. If a figure lacks quantity, renewal or qualifying commitment, it is a quote to clarify rather than proof of the cheapest complete order.
Branded tirzepatide evidence does not validate every compounded preparation. FDA recommends considering approved options and explaining the individual need for compounding. Treatment choice, concentration and dose should come from the clinician and pharmacy label rather than a price table.
Continue with Best month-to-month injection-plan comparisons: five ways to limit upfront commitment and Best GLP-1 programs with insurance support and a separate self-pay alternative.
Explore the review directory and full cost table to compare the details of another offer.
Official public information reviewed October 1, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.
Build a useful comparison from the next invoice, not the smallest number on the page.
Read the guide →The ingredient name is the beginning of the medicine discussion, not the complete answer.
Read the guide →Bring the information that turns an online assessment into a useful medical discussion.
Read the guide →